CapsoVision
NASDAQ: CVSaratoga, US · Delaware corporation · 1 known investors
Biotech
Founders & leadership
KH
Kang Huai WangNamed on SEC filing
HL
Hung Liang HsiehNamed on SEC filing
SS
Stephen S. C. WuNamed on SEC filing
Board
HC
Heidi ChungBoard director
PK
Patty KuoBoard director
MC
M.L. ChenBoard director
HH
H.L. HsiehBoard director
EH
Eli HarariBoard director
PT
Pen-Jung TsengBoard director
CT
Chen TsaiBoard director
HL
Howard LeeBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$100.4M disclosed across 6 rounds · 2014–2020
▶$64.8MraisedJul 2024 · 114 investors · BiotechnologyRule 506(b)
▶$64.8MraisedJul 2024 · 114 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Heidi ChungDirector
- Patty KuoDirector
- M.L. ChenDirector
- Eli HarariDirector
- Pen-Jung TsengDirector
- Chen TsaiDirector
- Howard LeeDirector
- Kang Huai WangExecutive Officer, Director
- Offering amount
- $64.8M
- Amount sold
- $64.8M
- First sale
- Nov 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$980KraisedJun 2020 · 7 investors · BiotechnologyRule 506(b)
▶$980KraisedJun 2020 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Pen-Jung TsengDirector
- Chen TsaiDirector
- Howard LeeDirector
- Kang Huai WangExecutive Officer, Director
- M.L. ChenDirector
- H.L. HsiehDirector
- Weili DaiDirector
- Peter ChouDirector
- Offering amount
- $5.5M
- Amount sold
- $980K
- First sale
- May 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$8MraisedOct 2018 · 8 investors · BiotechnologyRule 506(b)
▶$8MraisedOct 2018 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- H.L. HsiehDirector
- Peter ChouDirector
- Kang Huai WangExecutive Officer, Director
- Weili DaiDirector
- M.L. ChenDirector
- Chen TsaiDirector
- Pen-Jung TsengDirector
- Howard LeeDirector
- Offering amount
- $8M
- Amount sold
- $8M
- First sale
- Jan 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6.1MraisedOct 2018 · 11 investors · BiotechnologyRule 506(b)
▶$6.1MraisedOct 2018 · 11 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- H.L. HsiehDirector
- Chen TsaiDirector
- M.L. ChenDirector
- Howard LeeDirector
- Kang Huai WangExecutive Officer, Director
- Weili DaiDirector
- Peter ChouDirector
- Pen-Jung TsengDirector
- Offering amount
- $10M
- Amount sold
- $6.1M
- Minimum investment
- $20K
- First sale
- Aug 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4.6MraisedApr 2016 · 9 investors · BiotechnologyRule 506(b)
▶$4.6MraisedApr 2016 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- M.L. ChenDirector
- Pen-Jung TsengDirector
- Chen TsaiDirector
- Howard LeeDirector
- Kang Huai WangExecutive Officer, Director
- H.L. HsiehDirector
- Offering amount
- $15M
- Amount sold
- $4.6M
- First sale
- Mar 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$15.9MraisedFeb 2014 · 6 investors · BiotechnologyRule 506(c)
▶$15.9MraisedFeb 2014 · 6 investors · Biotechnology
Rule 506(c)Officers, directors & promoters on the filing
- Kang Huai WangExecutive Officer, Director
- Hung Liang HsiehDirector
- Stephen S. C. WuDirector
- Pen-Jung TsengDirector
- Offering amount
- $16.1M
- Amount sold
- $15.9M
- First sale
- Jan 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 1
by search overlapCompanies competing with CapsoVision for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- Who are CapsoVision's investors?
- CapsoVision's investors include Taiwan Global Angels.
- How much funding has CapsoVision raised?
- CapsoVision has disclosed $100.4M raised across 6 rounds.
- Where is CapsoVision headquartered?
- CapsoVision is headquartered in Saratoga, US.